Literature DB >> 26823826

Curcumin inhibits the proliferation and invasion of human osteosarcoma cell line MG-63 by regulating miR-138.

Dazhi Yu1, Fengmei An2, Xu He2, Xuecheng Cao3.   

Abstract

OBJECTIVE: In this study, we screened the different human osteosarcoma cell line MG-63 miRNAs after the treatment of curcumin and explored the effects of curcumin on MG-63 cells and its mechanism.
METHODS: Affemitrix miRNA chip was used to detect the changes of miRNA expression profile in MG-63 cells before and after curcumin treatment, and screen different expression of miRNAs. The target gene of miRNA was analyzed by bioinformatics. The expression levels of miRNA-138 target genes Smad4, NFκB p65 and cyclin D3 were detected. MTT and Transwell Cell invasion assays were used to observe the effects of curcumin on MG-63 cells.
RESULTS: Curcumin could significantly inhibit the proliferation of MG-63 cells and the expression levels of miRNA-138 target genes Smad4, NFκB p65 and cyclin D3 in MG-63 cells (P<0.05); overexpression of hsa-miR-138 down-regulated the expression levels of Smad4, NFκB p65 and cyclin D3 compared with the treatment of curcumin, while inhibition of hsa-miR-138 up-regulated the expression levels of Smad4, NFκB p65 and cyclin D3.
CONCLUSIONS: Curcumin could increase the expression of hsa-miR-138, hsa-miR-138 inhibited cell proliferation and invasive ability by inhibition of its target genes.

Entities:  

Keywords:  Curcumin; MG-63 cells; invasion; miR-138; miRNAs; proliferation

Mesh:

Substances:

Year:  2015        PMID: 26823826      PMCID: PMC4713612     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  19 in total

1.  Normalization of Affymetrix miRNA Microarrays for the Analysis of Cancer Samples.

Authors:  Di Wu; Michael P Gantier
Journal:  Methods Mol Biol       Date:  2016

2.  Curcumin regulates miR-21 expression and inhibits invasion and metastasis in colorectal cancer.

Authors:  Giridhar Mudduluru; Jonahunnatha N George-William; Santoshi Muppala; Irfan A Asangani; Regalla Kumarswamy; Laura D Nelson; Heike Allgayer
Journal:  Biosci Rep       Date:  2011-06       Impact factor: 3.840

3.  Global cancer statistics, 2002.

Authors:  D Max Parkin; Freddie Bray; J Ferlay; Paola Pisani
Journal:  CA Cancer J Clin       Date:  2005 Mar-Apr       Impact factor: 508.702

4.  Expression and clinical significance of cyclooxygenase-2 and microRNA-143 in osteosarcoma.

Authors:  Yongchao Fang; Zhiqiang Zhang; Qiang Wang; Jianning Zhao
Journal:  Exp Ther Med       Date:  2015-04-14       Impact factor: 2.447

5.  Induction of G1 Arrest by SB265610 Involves Cyclin D3 Down-regulation and Suppression of CDK2 (Thr160) Phosphorylation.

Authors:  Ahmed E Goda; Raymond L Erikson; Jong-Seog Ahn; Bo-Yeon Kim
Journal:  Anticancer Res       Date:  2015-06       Impact factor: 2.480

6.  Analysis of miRNA-gene expression-genomic profiles reveals complex mechanisms of microRNA deregulation in osteosarcoma.

Authors:  Georges Maire; Jeff W Martin; Maisa Yoshimoto; Susan Chilton-MacNeill; Maria Zielenska; Jeremy A Squire
Journal:  Cancer Genet       Date:  2011-03

7.  MicroRNA-144 acts as a tumor suppressor by targeting Rho-associated coiled-coil containing protein kinase 1 in osteosarcoma cells.

Authors:  Jianjun Huang; Ying Shi; Hui Li; Meisongzhu Yang; Guohong Liu
Journal:  Mol Med Rep       Date:  2015-06-16       Impact factor: 2.952

Review 8.  Roles of microRNA on cancer cell metabolism.

Authors:  Bing Chen; Hongbin Li; Xiao Zeng; Pengbo Yang; Xinyu Liu; Xia Zhao; Shufang Liang
Journal:  J Transl Med       Date:  2012-11-20       Impact factor: 5.531

9.  Munc18a does not alter fusion rates mediated by neuronal SNAREs, synaptotagmin, and complexin.

Authors:  Yunxiang Zhang; Jiajie Diao; Karen N Colbert; Ying Lai; Richard A Pfuetzner; Mark S Padolina; Sandro Vivona; Susanne Ressl; Daniel J Cipriano; Ucheor B Choi; Niket Shah; William I Weis; Axel T Brunger
Journal:  J Biol Chem       Date:  2015-02-25       Impact factor: 5.157

Review 10.  Role of microRNAs in schistosomes and schistosomiasis.

Authors:  Lihui Zhu; Jinming Liu; Guofeng Cheng
Journal:  Front Cell Infect Microbiol       Date:  2014-11-11       Impact factor: 5.293

View more
  13 in total

Review 1.  Effects of resveratrol, curcumin, berberine and other nutraceuticals on aging, cancer development, cancer stem cells and microRNAs.

Authors:  James A McCubrey; Kvin Lertpiriyapong; Linda S Steelman; Steve L Abrams; Li V Yang; Ramiro M Murata; Pedro L Rosalen; Aurora Scalisi; Luca M Neri; Lucio Cocco; Stefano Ratti; Alberto M Martelli; Piotr Laidler; Joanna Dulińska-Litewka; Dariusz Rakus; Agnieszka Gizak; Paolo Lombardi; Ferdinando Nicoletti; Saverio Candido; Massimo Libra; Giuseppe Montalto; Melchiorre Cervello
Journal:  Aging (Albany NY)       Date:  2017-06-12       Impact factor: 5.682

Review 2.  miRNA signatures in childhood sarcomas and their clinical implications.

Authors:  G M Viera; K B Salomao; G R de Sousa; M Baroni; L E A Delsin; J A Pezuk; M S Brassesco
Journal:  Clin Transl Oncol       Date:  2019-04-04       Impact factor: 3.405

3.  Induction of alpha-methylacyl-CoA racemase by miR-138 via up-regulation of β-catenin in prostate cancer cells.

Authors:  Kati Erdmann; Knut Kaulke; Christiane Rieger; Manfred P Wirth; Susanne Fuessel
Journal:  J Cancer Res Clin Oncol       Date:  2017-07-24       Impact factor: 4.553

4.  TDB protects vascular endothelial cells against oxygen-glucose deprivation/reperfusion-induced injury by targeting miR-34a to increase Bcl-2 expression.

Authors:  Li-Xi Liao; Ming-Bo Zhao; Xin Dong; Yong Jiang; Ke-Wu Zeng; Peng-Fei Tu
Journal:  Sci Rep       Date:  2016-11-25       Impact factor: 4.379

5.  Curcumin exerts its antitumor activity through regulation of miR-7/Skp2/p21 in nasopharyngeal carcinoma cells.

Authors:  Shaoyan Feng; Yu Wang; Rongkai Zhang; Guangwei Yang; Zibin Liang; Zhiwei Wang; Gehua Zhang
Journal:  Onco Targets Ther       Date:  2017-05-02       Impact factor: 4.147

6.  MicroRNA-138 directly targets TNFAIP8 and acts as a tumor suppressor in osteosarcoma.

Authors:  Zheng Zhou; Zhihong Li; Yi Shen; Tao Chen
Journal:  Exp Ther Med       Date:  2017-08-16       Impact factor: 2.447

7.  Analyzing the disease module associated with osteosarcoma via a network- and pathway-based approach.

Authors:  Yi Zhang; Fei Yang
Journal:  Exp Ther Med       Date:  2018-07-23       Impact factor: 2.447

Review 8.  Curcumin in Osteosarcoma Therapy: Combining With Immunotherapy, Chemotherapeutics, Bone Tissue Engineering Materials and Potential Synergism With Photodynamic Therapy.

Authors:  Chunfeng Xu; Mingjie Wang; Wei Guo; Wei Sun; Yuelian Liu
Journal:  Front Oncol       Date:  2021-05-20       Impact factor: 6.244

Review 9.  Two Worlds Colliding: The Interplay Between Natural Compounds and Non-Coding Transcripts in Cancer Therapy.

Authors:  Alexandru A Sabo; Maria Dudau; George L Constantin; Tudor C Pop; Christoph-M Geilfus; Alessio Naccarati; Mihnea P Dragomir
Journal:  Front Pharmacol       Date:  2021-07-06       Impact factor: 5.810

10.  The Curcumin Analog CH-5 Exerts Anticancer Effects in Human Osteosarcoma Cells via Modulation of Transcription Factors p53/Sp1.

Authors:  Felipe Teixeira Lima; Viviane Seba; Gabriel Silva; Guilherme Silva Torrezan; Carlos Roberto Polaquini; Vitor Caressato Pinhanelli; Seung J Baek; Ana Lúcia Fachin; Luis Octavio Regasini; Mozart Marins
Journal:  Int J Mol Sci       Date:  2018-06-29       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.